Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma
Overview
Authors
Affiliations
Intra-tumoral heterogeneity (ITH) is a complex multifaceted phenomenon that posits major challenges for the clinical management of cancer patients. Genetic, epigenetic, and microenvironmental factors are concurrent drivers of diversity among the distinct populations of cancer cells. ITH may also be installed by cancer stem cells (CSCs), that foster unidirectional hierarchy of cellular phenotypes or, alternatively, shift dynamically between distinct cellular states. Ependymoma (EPN), a molecularly heterogeneous group of tumors, shows a specific spatiotemporal distribution that suggests a link between ependymomagenesis and alterations of the biological processes involved in embryonic brain development. In children, EPN most often arises intra-cranially and is associated with an adverse outcome. Emerging evidence shows that EPN displays large intra-patient heterogeneity. In this review, after touching on EPN inter-tumoral heterogeneity, we focus on the sources of ITH in pediatric intra-cranial EPN in the framework of the CSC paradigm. We also examine how single-cell technology has shed new light on the complexity and developmental origins of EPN and the potential impact that this understanding may have on the therapeutic strategies against this deadly pediatric malignancy.
Long-read sequencing for brain tumors.
Shelton W, Zandpazandi S, Nix J, Gokden M, Bauer M, Ryan K Front Oncol. 2024; 14:1395985.
PMID: 38915364 PMC: 11194609. DOI: 10.3389/fonc.2024.1395985.
Modeling of brain tumors using , and microfluidic models: A review of the current developments.
Raju R R, AlSawaftah N, Husseini G Heliyon. 2024; 10(10):e31402.
PMID: 38807869 PMC: 11130649. DOI: 10.1016/j.heliyon.2024.e31402.
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities.
Isazadeh H, Oruji F, Shabani S, Behroozi J, Nasiri H, Isazadeh A Mol Biol Rep. 2023; 50(11):9529-9543.
PMID: 37741808 DOI: 10.1007/s11033-023-08749-y.
Savary C, Picard C, Corradini N, Castets M Int J Mol Sci. 2022; 23(11).
PMID: 35682989 PMC: 9181261. DOI: 10.3390/ijms23116310.
Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives.
Da-Veiga M, Rogister B, Lombard A, Neirinckx V, Piette C Cancers (Basel). 2022; 14(9).
PMID: 35565425 PMC: 9099564. DOI: 10.3390/cancers14092296.